Cytovale's IntelliSep Success: Enhancing Sepsis Care Nationwide Cytovale® has reported impressive outcomes from the IntelliSep sepsis test across multiple hospitals, showing significant reductions in mortality and resource use.

Cytovale's IntelliSep Success: Enhancing Sepsis Care Nationwide #United_States #San_Francisco #Cytovale #IntelliSep #sepsis

New Rapid Sepsis Test Reduces Hospital Mortality and Stay Duration Significantly Froedtert Hospital's study shows IntelliSep® test lowers mortality by 42% and cuts hospital stays by two days for infection patients, proving its effectiveness.

New Rapid Sepsis Test Reduces Hospital Mortality and Stay Duration Significantly #IntelliSep #sepsis #Froedtert_Hospital

Enhancing SEP-1 Compliance Through Early Sepsis Risk Assessment with IntelliSep A new study reveals how correctly utilizing IntelliSep for sepsis risk assessment can boost SEP-1 compliance by 29%, enhancing patient care.

Enhancing SEP-1 Compliance Through Early Sepsis Risk Assessment with IntelliSep #United_States #Cytovale #IntelliSep #Baton_Rouge #sepsis

Cytovale’s IntelliSep Revolutionizes Sepsis Testing With Significant ED Discharge Increases A recent study highlights how Cytovale's IntelliSep® dramatically boosts ED discharges for low-risk sepsis patients, enhancing patient safety and resource allocation.

Cytovale’s IntelliSep Revolutionizes Sepsis Testing With Significant ED Discharge Increases #USA #San_Francisco #Cytovale #IntelliSep #Sepsis_Testing

Cytovale's IntelliSep® Diagnostic Achieves 39% Reduction in Sepsis Mortality Rates A groundbreaking study reveals Cytovale's IntelliSep® significantly decreases sepsis mortality by 39%. This rapid diagnostic transforms emergency care.

Cytovale's IntelliSep® Diagnostic Achieves 39% Reduction in Sepsis Mortality Rates #USA #Cytovale #IntelliSep #Baton_Rouge #sepsis

New Research Reveals ICU-Level Care Does Not Guarantee Accurate Sepsis Diagnosis A recent study presented at the SHM Converge conference indicates that ICU-level care may not effectively identify sepsis, urging for more reliable diagnostic tools for timely intervention.

New Research Reveals ICU-Level Care Does Not Guarantee Accurate Sepsis Diagnosis #United_States #Cytovale #IntelliSep #Baton_Rouge #sepsis

Cytovale Appoints Rhonda Collins as Chief Nursing Officer to Enhance Sepsis Detection Efforts Cytovale has named Rhonda Collins as Chief Nursing Officer, aiming to expand the implementation of nurse-driven protocols for rapid sepsis detection across hospitals in the U.S.

Cytovale Appoints Rhonda Collins as Chief Nursing Officer to Enhance Sepsis Detection Efforts #United_States #San_Francisco #Cytovale #IntelliSep #Rhonda_Collins

Cytovale's IntelliSep® Leads the Charge in Sepsis Detection with Record Growth in 2025 Cytovale's IntelliSep® has revolutionized sepsis detection, showing significant clinical benefits and business growth, marking a pivotal year in healthcare.

Cytovale's IntelliSep® Leads the Charge in Sepsis Detection with Record Growth in 2025 #USA #San_Francisco #sepsis_detection #Cytovale #IntelliSep

Cytovale's IntelliSep Receives Modern Healthcare's Best in Business Award for 2024 Cytovale's IntelliSep technology has been recognized by Modern Healthcare as one of the best in business for 2024. This award underscores its role in improving patient care.

Cytovale's IntelliSep Receives Modern Healthcare's Best in Business Award for 2024 #United_States #San_Francisco #Modern_Healthcare #Cytovale #IntelliSep

Cytovale's Game-Changing Sepsis Detection Technology in Rural Louisiana Cytovale's IntelliSep technology is now implemented in Our Lady of the Lake Ascension hospital to improve sepsis detection in rural areas.

Cytovale's Game-Changing Sepsis Detection Technology in Rural Louisiana #United_States #Gonzales #Cytovale #IntelliSep #Louisiana